Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes.

MC, Bunck; B, Eliasson; A, Cornér; RJ, Heine; RM, Shaginian; MR, Taskinen; H, Yki-Järvinen; U, Smith; M, Diamant

doi:10.1111/j.1463-1326.2010.01355.x

Public

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes.

Shared by NobleBlocks on Apr 1, 2011 • 12:00 AM UTC

Authors:

Bunck MC

Eliasson B

Cornér A

Abstract

Preclinical studies suggest that incretin-based therapies may be beneficial for the bone; however, clinical data are largely lacking. We assessed whether the differential effects of these therapies on body weight differed with respect to their effect on bone mineral density (BMD) and markers of calc...

Discussions